EDITORIALS

Pediatric Hodgkin’s Therapy: Time for a Paradigm Shift

Melissa M. Hudson

JCO Sep 15 2002: 3755–3757. [Full Text] [PDF]

Endostatin: Are the 2 Years Up Yet?

Jan H. M. Schellens and Mark J. Ratain

JCO Sep 15 2002: 3758–3760. [Full Text] [PDF]

The "Cure" for Cancer: Can the Media Report the Hope Without the Hype?

Christopher K. Daugherty

JCO Sep 15 2002: 3761–3764. [Full Text] [PDF]

ORIGINAL REPORTS
Pediatric Oncology
	Randomized Comparison of Low-Dose Involved-Field Radiotherapy and No Radiotherapy for Children With Hodgkin’s Disease Who Achieve a Complete Response to Chemotherapy
	James B. Nachman, Richard Sposto, Philip Herzog, Gerald S. Gilchrist, Suzanne L. Wolden, John Thomson, Marshall E. Kadin, Paul Pattengale, P. Charlton Davis, Raymond J. Hutchinson, and Keith White
	JCO Sep 15 2002: 3765–3771. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology
	Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated Daily
	Joseph P. Eder, Jr, Jeffrey G. Supko, Jeffrey W. Clark, Thomas A. Puchalski, Rocio Garcia-Carbonero, David P. Ryan, Lawrence N. Shulman, Joann Proper, Moira Kirvan, Barbara Rattner, Susan Connors, Mary T. Keogan, Milos J. Janicek, William E. Fogler, Lowell Schnipper, Nancy Kinchla, Carolyn Sidor, Eric Phillips, Judah Folkman, and Donald W. Kufe
	JCO Sep 15 2002: 3772–3784. First published on Jun 17 2002; 10.1200/JCO.2002.02.082. [Abstract] [Full Text] [PDF]
	Study of the Media’s Potential Influence on Prospective Research Participants’ Understanding of and Motivations for Participation in a High-Profile Phase I Trial
	Rebecca D. Pentz, Anne L. Flamm, Jeremy Sugarman, Marlene Z. Cohen, G. Daniel Ayers, Roy S. Herbst, and James L. Abbruzzese
	JCO Sep 15 2002: 3785–3791. First published on Jul 1 2002; 10.1200/JCO.2002.04.084. [Abstract] [Full Text] [PDF]
	Phase I Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors
	Roy S. Herbst, Kenneth R. Hess, Hai T. Tran, Jennifer E. Tseng, Nizar A. Mullani, Chusilp Charnsangavej, Timothy Madden, Darren W. Davis, David J. McConkey, Michael S. O’Reilly, Lee M. Ellis, James Pluda, Waun K. Hong, and James L. Abbruzzese
	JCO Sep 15 2002: 3792–3803. First published on Jul 29 2002; 10.1200/JCO.2002.11.061. [Abstract] [Full Text] [PDF]
	Development of Biologic Markers of Response and Assessment of Antiangiogenic Activity in a Clinical Trial of Human Recombinant Endostatin
	Roy S. Herbst, Nizar A. Mullani, Darren W. Davis, Kenneth R. Hess, David J. McConkey, Chusilp Charnsangavej, Michael S. O’Reilly, Hyung-Woo Kim, Cheryl Baker, Jennifer Roach, Lee M. Ellis, Asif Rashid, James Pluda, Corazon Bucana, Timothy L. Madden, Hai T. Tran, and James L. Abbruzzese
	JCO Sep 15 2002: 3804–3814. First published on Aug 12 2002; 10.1200/JCO.2002.05.102. [Abstract] [Full Text] [PDF]
	Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 Is Generally Well-Tolerated and Has Activity in Non–Small-Cell Lung Cancer and Other Solid Tumors: Results of a Phase I Trial
	Roy S. Herbst, Anne-Marie Maddox, Mace L. Rothenberg, Eric J. Small, Eric H. Rubin, Jose Baselga, Federico Rojo, Waun Ki Hong, Helen Swaisland, Steven D. Averbuch, Judith Ochs, and Patricia Mucci LoRusso
	JCO Sep 15 2002: 3815–3825. [Abstract] [Full Text] [PDF]
	Effects of 5,6-Dimethylxanthenone-4-Acetic Acid on Human Tumor Microcirculation Assessed by Dynamic Contrast-Enhanced Magnetic Resonance Imaging
	Susan M. Galbraith, Gordon J.S. Rustin, Martin A. Lodge, N. Jane Taylor, J. James Stirling, Michael Jameson, Paul Thompson, David Hough, Lindsey Gumbrell, and Anwar R. Padhani
	JCO Sep 15 2002: 3826–3840. [Abstract] [Full Text] [PDF]
	Pegylated Interferon Alfa-2b Treatment for Patients With Solid Tumors: A Phase I/II Study
	Ronald Bukowski, Marc S. Ernstoff, Martin E. Gore, John J. Nemunaitis, Robert Amato, Samir K. Gupta, and Craig L. Tendler
	JCO Sep 15 2002: 3841–3949. [Abstract] [Full Text] [PDF]

Head and Neck Cancer
	Lack of Expression of Galectin-3 Is Associated With a Poor Outcome in Node-Negative Patients With Laryngeal Squamous-Cell Carcinoma
	Mauro Piantelli, Stefano Iacobelli, Giovanni Almadori, Manuela Iezzi, Nicola Tinari, Clara Natoli, Gabriella Cadoni, Libero Lauriola, and Franco O. Ranelletti
	JCO Sep 15 2002: 3850–3856. [Abstract] [Full Text] [PDF]

Breast Cancer
	Phase II Multicenter Trial of a Weekly Paclitaxel and Carboplatin Regimen in Patients With Advanced Breast Cancer
	David Loesch, Nicholas Robert, Lina Asmar, Mary Ann Gregurich, Mark O’Rourke, Shaker Dakhil, and Edwin Cox
	JCO Sep 15 2002: 3857–3864. [Abstract] [Full Text] [PDF]

Lung Cancer
	Clinical Significance of p21 Expression in Non–Small-Cell Lung Cancer
	Tsuyoshi Shoji, Fumihiro Tanaka, Tetsuya Takata, Kazuhiro Yanagihara, Yosuke Otake, Nobuharu Hanaoka, Ryo Miyahara, Tatsuo Nakagawa, Yozo Kawano, Shinya Ishikawa, Hiromichi Katakura, and Hiromi Wada
	JCO Sep 15 2002: 3865–3871. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Treatment of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Type With Cladribine: A Phase II Study
	Gerald Jäger, Peter Neumeister, Ruth Brezinschek, Thomas Hinterleitner, Wolfgang Fiebiger, Melitta Penz, Hans J. Neumann, Brigitte Mlineritsch, Maria DeSantis, Franz Quehenberger, Andreas Chott, Christine Beham-Schmid, Gerald Höfler, Werner Linkesch, and Markus Raderer
	JCO Sep 15 2002: 3872–3877. [Abstract] [Full Text] [PDF]
	Therapy-Related Myeloid Leukemias Are Observed in Patients With Chronic Lymphocytic Leukemia After Treatment With Fludarabine and Chlorambucil: Results of an Intergroup Study, Cancer and Leukemia Group B 9011
	Vicki A. Morrison, Kanti R. Rai, Bercedis L. Peterson, Jonathan E. Kolitz, Laurence Elias, Frederick R. Appelbaum, John D. Hines, Lois Shepherd, Richard A. Larson, and Charles A. Schiffer
	JCO Sep 15 2002: 3878–3884. [Abstract] [Full Text] [PDF]
	Subsequent Chemotherapy Regimens Are Well Tolerated After Radioimmunotherapy With Yttrium-90 Ibritumomab Tiuxetan for Non-Hodgkin’s Lymphoma
	Stephen M. Ansell, Kay M. Ristow, Thomas M. Habermann, Gregory A. Wiseman, and Thomas E. Witzig
	JCO Sep 15 2002: 3885–3890. [Abstract] [Full Text] [PDF]
	Alemtuzumab in Previously Treated Chronic Lymphocytic Leukemia Patients Who Also Had Received Fludarabine
	K. R. Rai, C. E. Freter, R. J. Mercier, M. R. Cooper, B. S. Mitchell, E. A. Stadtmauer, P. Santábarbara, B. Wacker, and L. Brettman
	JCO Sep 15 2002: 3891–3897. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Prognostic Value of KIT Mutation Type, Mitotic Activity, and Histologic Subtype in Gastrointestinal Stromal Tumors
	Samuel Singer, Brian P. Rubin, Marcia L. Lux, Chang-Jie Chen, George D. Demetri, Christopher D.M. Fletcher, and Jonathan A. Fletcher
	JCO Sep 15 2002: 3898–3905. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Mechanisms and Future Directions for Angiogenesis-Based Cancer Therapies
	Frank A. Scappaticci
	JCO Sep 15 2002: 3906–3927. [Abstract] [Full Text] [PDF]

SPECIAL DEPARTMENTS

CORRESPONDENCE

p53 and MDM2 in Germ Cell Cancer Treatment Response

R.T.D. Oliver, J. Shamash, D.M. Berney, Frank Mayer, Anne-Marie Kersemaekers, J. Wolter Oosterhuis, Carsten Bokemeyer, and Leendert H.J. Looijenga

JCO Sep 15 2002: 3928–3929. [Full Text] [PDF]

Adjuvant Radiation for Stage IIB Soft Tissue Sarcoma of the Extremity

Robert D. Timmerman and Kaled M. Alektiar

JCO Sep 15 2002: 3929–3930. [Full Text] [PDF]

Colostomies May Influence Patient Quality of Life More Than Poor Sphincter Function

Jacqueline Kerr, Jutta Engel, Dieter Hölzel, and Bruce D. Minsky

JCO Sep 15 2002: 3930–3931. [Full Text] [PDF]

Screening for Lung Cancer

Matti Hakama and Gary M. Strauss

JCO Sep 15 2002: 3931–3934. [Full Text] [PDF]

Ethical Issues Surrounding the Conduct of Off-Shore Clinical Research

Anne Hamilton and Richard R. Love

JCO Sep 15 2002: 3934–3936. [Full Text] [PDF]

Nonovarian Pelvic Cancers in BRCA1/2 Mutation Carriers and the BRCAPRO Statistical Model

Carol Cremin, Nora Wong, Karen Buzaglo, Ann-Josée Paradis, William Foulkes, D.A. Berry, G. Parmigiani, W. Rubinstein, and P. Watson

JCO Sep 15 2002: 3936–3937. [Full Text] [PDF]

Chronomodulated Chemotherapy in Advanced Colorectal Carcinoma

Tim Price, Chris Karapetis, Virginie Chevalier, Hervé Curé, Philippe Chollet, and Francis Lévi

JCO Sep 15 2002: 3937–3939. [Full Text] [PDF]

ERRATA

JCO Sep 15 2002: 3939. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.